HR 7482119th CongressIn Committee
LymeX Authorization Act
Standard Summary
Balanced plain-English summary
The LymeX Authorization Act, introduced by Representative Smith of New Jersey and Mr. Doggett, authorizes the Secretary of Health and Human Services to fund prize competitions aimed at accelerating innovation in the prevention, diagnosis, and treatment of Lyme disease. The bill states a federal policy of engaging stakeholders such as academia, nonprofits, industry, and government, fostering public awareness and education, and developing rapid, patient-focused next-generation diagnostics, and it authorizes $5 million for these prize competitions.
Key Points
- 1Authorizes $5 million for HHS prize competitions on Lyme disease innovation.
- 2Establishes federal policy to engage stakeholders in patient-centered Lyme disease care.
- 3Promotes public awareness and health education initiatives for Lyme disease.
- 4Aims to accelerate development of rapid, patient-focused next-generation diagnostics.
- 5Prize competitions defined under the Stevenson-Wydler Technology Innovation Act of 1980.
Impact Areas
Lyme disease patientsHHS and public health agenciesMedical researchers and academiaDiagnostics and biotech industryNonprofit health organizations
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026